Our Mission
Mitochondria at the Heart of Drug Development
Our mission is to put mitochondrial biology at the forefront of drug discovery, enabling earlier, more informative screening and a deeper understanding of drug-induced toxicity. By developing innovative technologies that reveal functional changes in mitochondrial biology, we aim to improve how potential medicines are identified, characterised and prioritised — helping researchers make better decisions earlier, reduce late-stage failures and ultimately accelerate the discovery of safer, more effective medicines.
Capabilities
End-to-End Proprietary Technologies & Integrated Discovery Capabilities
Our proprietary technology stack brings together advanced screening, flow cytometry, microscopy, functional assay development, data aggregation and toxicity discovery within a single, integrated platform. These complementary capabilities enable us to move from biological measurement and early-stage screening through to actionable data and discovery — providing researchers with deeper functional insight, earlier identification of risk and greater confidence in advancing the most promising candidates.
Technologies
Innovating the Next Generation of Screening Technologies
We develop breakthrough screening technologies designed to push the boundaries of what is possible in drug discovery. By combining novel approaches to biological measurement with advanced imaging, sensing and data technologies, we seek to uncover new ways of understanding cellular function, drug response and toxicity. Our focus is on creating more sensitive, functional and informative screening approaches that enable earlier insight and help drive the next generation of medicine.